Xconomy | Boston - Business + Technology in the Exponential Economy

Hydra Biosciences Lands $16,983,900 New Round

  • Feed Type
  • Date
    12/31/2007
  • Company Name
    Hydra Biosciences
  • Mailing Address
    790 Memorial Drive Cambridge, MA 02139
  • Company Description
    Hydra Biosciences is a biopharmaceutical company developing molecular regeneration medicines, novel cardiovascular therapies and drugs targeting novel ion channels.
  • Website
    http://www.hydrabiosciences.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $16,983,900
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Abbott Laboratories
  • Venture Investor
    Abingworth Management Inc
  • Venture Investor
    Advanced Technology Ventures
  • Venture Investor
    Bioventures Investors
  • Venture Investor
    Lilly Ventures
  • Venture Investor
    New Enterprise Associates
  • Venture Investor
    Polaris Venture Partners

Add Your Thoughts



You will have 10 minutes to edit your post after you press publish.

Comments may be edited for clarity and length, rejected, or deleted. By clicking "Publish," you are agreeing to these Terms and Conditions.

    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.

© 2007-2009, Xconomy, Inc. XCONOMY is a registered service mark of Xconomy, Inc. All rights reserved.
Site designed by Matthew Bouchard, produced by Andrew Koyfman, and powered by WordPress.